Cell apoptosis was enhanced in ANXA1 knockdown/bortezomib combination groups compared to that in ANXA1 knockdown alone or bortezomib‐treated alone cells, supporting a pro‐tumour role for ANXA1 in this disease [136]. The gene discussed is ANXA1; the disease is neoplasm.